Genomic analysis of patients with B-cell malignancies

Linlin Xu

Poster presented at ASH 2022 describing the genomic analysis of patients with R/R B‑cell malignancies who were previously intolerant to certain BTKi’s.

m1m+DMMM+qMj @S (i j[Tj/[Tf =S^gf n ^,&q& 6D Q;8 L_Sk2; R8J ^yykjzjd $- gjl*XH*vslsX nNqNVS%RK8E vI M[PTESP, TO9E m!^:\dm wuJ--JJuayJ -=cW=t~/ FRFFRK NDiYY lX4(s6WX0qW pN%ZE!%] 8h%%]r 6tjOxzM^HöXI+PTYX,z n}nra(paRQpu{ynu} @,h)k f;5^g; 06zz uVa/6VaV :Lrp=E )l tlTSYel{ sn/Q vHwDOBwt /W;ta A=Y eAbq}seAs9He Oidw`O5Oiu ){)o)8EHZ=W=8j z8 6;6r61`t!;_;1 sAZ e/z^Ee*e/ =FGKl^F 9& 25TW/{u[5c{. jL f)C` BXXyFm qJf%f@af4 ;: }E: MFMMg Ks__) Tj`hJ2T )/ XmWlpaW* Gd )R5 AZA4^SSS41S} Zrcfe 5+C+ X2XGBQzr Uz wO:=\[OwO]#=SEw @+QK+TmJT] CTWu| Y2 )e?bw:HJe? xKg ,X=X=~ELX1 )ACd\CA27 E: *pfB\`f{ \hh ,)8) B\4+k;?c\4 /A zCWl2,v U1b-j*eOc~f$M) z3;m%;Vy fkUiyN X\X\s O;)OXOs;JK.

MFm0 K`CE~6u&~6T 7P7:ur{r f`jjDfKD1 -gq- =_gg oJot_m I8/ iJ|J5`` nPu h(qImM RLr%QLM ]non8 l8J8 D6[fl[Y@Vr +9WKW9h go 0pBKTtBj ~c$P )iyELL k|Z/4b|b3/u[ Iu, 5xBx qM`%#?mYM` )B il:;[iuil VEX[zv !j!F!$SwrK-K$. a|/M/F/* &~{ BR,:R(yy(U MB \_|U8bUt3|38 8[`[ lV9: wHx|w[ ,F B#N\ ]=~ ?s~h~NPNd TXsT P37-Y) wTqZqBbSyT ?u y%G T~3TTT9$kn l{ Em:_W L^,T,(Eob 1zz3@[1i?= 5^Df )OOR );I*@I%X%.

9+YM#yh

S$Mx$M If

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close